cysteine has been researched along with prasugrel hydrochloride in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blair, PE; Farid, NA; Gillespie, TA; Goldberg, MJ; Kurihara, A; Rash, TJ; Smith, RL | 1 |
| Algaier, I; Asai, F; Jakubowski, JA; von Kügelgen, I | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for cysteine and prasugrel hydrochloride
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for cysteine and prasugrel hydrochloride
| Article | Year |
|---|---|
The disposition of prasugrel, a novel thienopyridine, in humans.
Topics: Administration, Oral; Biotransformation; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Cysteine; Feces; Humans; Hydrolysis; Intestinal Absorption; Male; Methylation; Molecular Structure; Oxidation-Reduction; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prodrugs; Pyridines; Reference Values; Tandem Mass Spectrometry; Thiophenes | 2007 |
1 other study(ies) available for cysteine and prasugrel hydrochloride
| Article | Year |
|---|---|
Interaction of the active metabolite of prasugrel, R-138727, with cysteine 97 and cysteine 175 of the human P2Y12 receptor.
Topics: Animals; Binding Sites; CHO Cells; Cricetinae; Cricetulus; Cysteine; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Thiophenes; Transduction, Genetic | 2008 |